Generation of a monoclonal antibody against human calreticulin by immunization with a recombinant calreticulin fusion protein: Application in paraffin-embedded sections

Applied Immunohistochemistry

Volumn 7, Issue 2, 1999, Pages 150-155

  Cavill, Dana ^a   Macardle, Peter J ^a   Beroukas, Dimitra ^a   Kinoshita, Gentaro ^a   Stahl, Jurgen ^a   McCluskey, James ^b   Gordon, Tom P ^a,c  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Calreticulin; Human tissues; Immunolocalization

Indexed keywords

CALRETICULIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING;

EID: 0032863867     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199906000-00008     Document Type: Article

References (16)

1. Bini L, Magi B, Marzocchi B, et al. Protein expression profiles in human breast ductal and histologically normal tissue. Electrophoresis 1997;18:2832-41.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of a protein utilising the principle of protein dye binding. Anal Biochem 1976;72:248-55.
3. Cheng S-T, Nguyen TQ, Yang Y-S, Capra JD, Sontheimer RD. Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol 1996; 156:4484-91.
4. Donohoe PJ, Macardle PJ, Zola H. Making conventional monoclonal antibodies. In: Zola H, ed. Monoclonal antibodies: the second generation. Oxford: Bios Scientific, 1994:15-42.
5. Eggleton P, Lieu TS, Zappi EG, et al. Calreticulin is released from activated neutrophils and binds to Clq and mannan-binding protein. Clin Immunol Immunopathol 1994;72:405-9.
6. Franzen B, Linder S, Alaiya AA, et al. Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br J Cancer 1996;73:1632-8.
7. 2+ storing site in PtK2 cells during interphase and mitosis: an immunocytochemical study using an antibody against calreticulin. Eur J Cell Biol 1995;66:82-93.
8. Jacob L, Roznowski AB, Houen G, Gromnica-Ihle E, Meyer TF, Zevering Y. Evidence for human calreticulin as an autoantigen specifically recognised by T cells of immunocompetent patients with rheumatoid arthritis and other arthritides [Abstract]. Arthritis Rheum 1997;40:197.
9. Keech CL, Gordon TP, McCluskey J. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 1996;157:3694-9.
10. Kinoshita G, Keech CL, Sontheimer RD, Purcell A, McCluskey J, Gordon TP. Spreading of the immune response from 52kD Ro and 60kD Ro to calreticulin in experimental autoimmunity. Lupus 1997;7:7-11.
11. Krause K-H, Michalak M. Calreticulin. Cell 1997;88:439-43.
12. Peterson KL, Zhang W, Lu PD, Keilbaugh SA, Peerschke EIB, Ghebrehiwet B. The Clq binding cell membrane proteins cClq-R and gClq-R are released from activated cells: subcellular distribution and immunochemical characterisation. Clin Immunol Immunopathol 1997;84:17-26.
13. Shi S-R, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 1993;41:1599-604.
14. Sontheimer RD, Nguyen TQ, Cheng ST, Lieu TS, Capra JD. The unveiling of calreticulin: a clinically relevant tour of modern cell biology. J Invest Med 1995;43:362-70.
15. Werth VP, Dutz JP, Sontheimer RD. Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus. Curr Opin Rheumatol 1997;9:400-9.
16. ++-binding protein abundantly expressed and regulated by androgen in prostatic epithelial cells. Endocrinology 1998;139:4337-4.